These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35205698)

  • 1. Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.
    Stie M; Delmar C; Nørgaard B; Jensen LH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.
    Stie M; Delmar C; Nørgaard B; Jensen LH
    BMJ Open; 2022 Apr; 12(4):e059960. PubMed ID: 35470199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open dialogue about complementary and alternative medicine (CAM) integrated in conventional oncology care, characteristics and impact. A systematic review.
    Stie M; Jensen LH; Delmar C; Nørgaard B
    Patient Educ Couns; 2020 Nov; 103(11):2224-2234. PubMed ID: 32563705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: a randomised controlled trial.
    Chong WQ; Mogro MJ; Arsad A; Tai BC; Lee SC
    Support Care Cancer; 2021 Jul; 29(7):3689-3696. PubMed ID: 33188612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer.
    Jefford M; Gough K; Drosdowsky A; Russell L; Aranda S; Butow P; Phipps-Nelson J; Young J; Krishnasamy M; Ugalde A; King D; Strickland A; Franco M; Blum R; Johnson C; Ganju V; Shapiro J; Chong G; Charlton J; Haydon A; Schofield P
    Oncologist; 2016 Aug; 21(8):1014-23. PubMed ID: 27306909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Gonzalez L; Jacobsen P; Cox CE
    Oncol Nurs Forum; 2006 Jan; 33(1):97-104. PubMed ID: 16470237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
    Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
    Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.
    Mobed K; Liu R; Stewart S; Wrensch M; McCoy L; Rice T; Prados M; Chang S
    J Support Oncol; 2009; 7(6):W23-W31. PubMed ID: 26692824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy.
    Niska JR; Thorpe CS; Halyard MY; Tan AD; Atherton PJ; Dueck AC; Patel SH; Sloan JA
    J Patient Rep Outcomes; 2020 Jul; 4(1):60. PubMed ID: 32677021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
    Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of integrating individualized and generic complementary medicine treatments with standard care versus standard care alone for reducing preoperative anxiety.
    Attias S; Keinan Boker L; Arnon Z; Ben-Arye E; Bar'am A; Sroka G; Matter I; Somri M; Schiff E
    J Clin Anesth; 2016 Mar; 29():54-64. PubMed ID: 26897450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Impact, Complementary/Alternative Medicine Beliefs, and Quality of Life in Cancer Patients.
    Kuo YH; Tsay SL; Chang CC; Liao YC; Tung HH
    J Altern Complement Med; 2018 Mar; 24(3):276-281. PubMed ID: 28876080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.
    Klafke N; Mahler C; von Hagens C; Rochon J; Schneeweiss A; Müller A; Salize HJ; Joos S
    Trials; 2015 Feb; 16():51. PubMed ID: 25887713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study.
    Wode K; Henriksson R; Sharp L; Stoltenberg A; Hök Nordberg J
    BMC Complement Altern Med; 2019 Mar; 19(1):62. PubMed ID: 30866916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients.
    Paepke D; Wiedeck C; Hapfelmeier A; Karmazin K; Kiechle M; Brambs C
    Breast Care (Basel); 2020 Aug; 15(4):380-385. PubMed ID: 32982648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and Alternative Medicine Use and Symptom Burden in Women Undergoing Chemotherapy for Breast Cancer in Malaysia.
    Chui PL; Abdullah KL; Wong LP; Taib NA
    Cancer Nurs; 2018; 41(3):189-199. PubMed ID: 28723722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context.
    Tilburt J; Yost KJ; Lenz HJ; Zúñiga ML; O'Byrne T; Branda ME; Leppin AL; Kimball B; Fernandez C; Jatoi A; Barwise A; Kumbamu A; Montori V; Koenig BA; Geller G; Larson S; Roter DL
    Oncologist; 2019 Nov; 24(11):e1180-e1189. PubMed ID: 31101701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.
    Tasaki K; Maskarinec G; Shumay DM; Tatsumura Y; Kakai H
    Psychooncology; 2002; 11(3):212-20. PubMed ID: 12112481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.
    Jang A; Kang DH; Kim DU
    J Altern Complement Med; 2017 May; 23(5):362-369. PubMed ID: 28453297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.